Search Cancer Clinical Trials

Mass General Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
8 results
  • Thyroid Cancer, Pancreatic Cancer, Ovarian Cancer, Lung Cancer, Liver Cancer, Kidney Cancer, Sarcoma, Breast Cancer, Head and Neck Cancer

23-301          Phase I

A First-in-Human, Open-label, Multicenter, Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PYX-201 in Participants with Advanced Solid Tumors

  • Sarcoma, Pancreatic Cancer, Liver Cancer, Gastric (Stomach) Cancer, Endometrial Cancer, Bladder Cancer, Esophageal Cancer

20-544          Phase II

A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Advanced Solid Tumors Harboring a p53 Y220C Mutation

  • Liver Cancer

22-625          Phase II

A Phase 1/2, Safety Confirmation and Double-blind, Placebo-controlled, Randomized Study of Relatlimab in Combination with Nivolumab and Bevacizumab in Treatment-naïve Advanced/Metastatic Hepatocellular Carcinoma (RELATIVITY-106)

  • Liver Cancer

21-410          N/A

A prospective, multicenter, open-label single arm study evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin microspheres on duration of response (DoR) and objective response rate (ORR) in unresectable hepatocellular carcinoma (HCC) patients (DOORwaY90 Study)

  • Gastric (Stomach) Cancer, Pancreatic Cancer, Liver Cancer

22-398          N/A

Generating Artificial Intelligence MR-based Upper Abdomen Pseudo-CT Images for Radiation Therapy Planning

  • Liver Cancer

17-733          Phase III

NRG-GI003: A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma

  • Liver Cancer

23-394          Phase III

Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen

  • Liver Cancer

21-286          Phase I

Phase IB Study of Atezolizumab and Bevacizumab with SBRT for Unresectable Hepatocellular Carcinoma

Showing 1 - 10 of 8 results